26 Acquisition International - Issue 6 2022 Apr22447 Accelerating Time to Market for Biopharma and Medtech Digital Solutions stablished in 2018, BrightInsight boasts a client roster that includes many of the top global biopharma and medtech companies. The BrightInsight® Platform is considered the de facto platform for building regulated apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD). Introducing BrightInsight to us, CEO, and Co-Founder, Dr. Kal Patel, begins, “BrightInsight provides the leading global platform for biopharma and medtech regulated digital health solutions.” Kal points out that biopharma and medtech are highly regulated industries. But unlike the financial and automotive industries that are also regulated, healthcare has been slower to adopt digital technology. The BrightInsight Platform has enabled the adoption of digital by the biopharma and medtech industry, ensuring security, privacy, and regulatory compliance. Serving leading global biopharma and medtech businesses – including Novo Nordisk, Roche, CSL Behring, UCB, Sanofi, and many more – BrightInsight works with a wide range of organizations looking to improve patient care. Kal tells us, “We value partnership. We are strategic partners to our customers and our team collaborates every day to achieve our vision of transforming patient outcomes globally by bringing the power of digital technology to healthcare.” “We are the partner of choice for innovative and forward-looking companies because of our team’s expertise and experience building digital solutions for biopharma and medtech; our platform’s reliability that ensures future-proofed scale; and our global footprint and experience,” Kal explains. With the team’s wealth of experience and focus on its mission, BrightInsight helps its clients build digital tools that support and improve the patient journey. Kal adds, “Whether they are developing a companion app to a leading drug to improve adherence, adding connectivity to a medical device, or deploying a smart algorithm to personalize patient care in real-time, we help our customers build, deploy, scale, and maintain these digital solutions in a compliant manner across disease states, products and geographies.” BrightInsight’s Platform is available in 48 countries around the globe. E With BrightInsight partnering with many of the top biopharma and medtech companies, it has established itself as the industry’s premier digital partner. Kal shares, “With the BrightInsight Platform as their foundation and BrightInsight as their launch partner, our customers are accelerating time to market for apps, algorithms, medical devices, connected combination products, diagnostics and Software as a Medical Device.” Its platform offers configurable applications that accelerate time to market, with projects moving from initiation to launch in 6-12 months. BrightInsight’s data integration, data management, and analytics allow biopharma and medtech businesses to build solutions quickly. With pre-built integrations with medical devices, Electronic Health Records, and other health IT systems, BrightInsight paves the way for easier access and sharing of data across its platform. By managing the data in an expert fashion, the aggregation and advanced data processing enables diagnosis, prevention, and treatment of clinical conditions with ease. With its experience supporting regulated products across therapy areas including diabetes, respiratory, oncology, ophthalmology, obesity, haematology, immunology, neurology, and more, BrightInsight improves the customer experience alongside the success rate of each biopharma and medtech company that it helps to expand and succeed. BrightInsight has received industry recognition including as Google Cloud Technology Partner of the Year for Healthcare for two consecutive years, was ranked 13 on LinkedIn’s Top Start-ups List in 2020, named as the CB Insights Digital Health 150 two years in a row, and named a Digital Health Start-up to Watch in 2021 by Medical Design and Outsourcing. BrightInsight strives to create a team first approach to its structure and internal culture – and parallel to this – Kal says, “Our company culture plays a key role in our success. We hire and then continue to cultivate that culture. Among the qualities we look for, the first is passion. Our people are incredibly passionate about our mission to drive improvement in clinical outcomes with digital. And second, our culture emphasizes a real sense of accountability to identify and solve problems for our customers.” Highly regarded and fully compliant with global security, privacy, and regulatory requirements, BrightInsight has built a digital platform that enables global biopharma and medtech companies to build digital solutions to improve patient care and outcomes. We speak to BrightInsight’s CEO, and Co-Founder, Kal Patel, M.D., about BrightInsight as it wins Most Innovative Digital Health Solutions Platform 2022 – USA.
RkJQdWJsaXNoZXIy MTQxNTg3MQ==